Farmacoeconomía aplicada al tratamiento postquirúrgico de cataratas y pterigión en pacientes de la Fundación Internacional Buen Samaritano Paúl Martel (FIBUSPAM) de la ciudad de Riobamba.

Abstract

The present work of degree had the objective of evaluating analysis pharmacoeconomics applied to the post-surgical treatment of cataracts and pterygium in patients of the Fundación Internacional Buen Samaritano Paúl Martel (FIBUSPAM) of the city of Riobamba. For the realization of this research developed an epidemiological profile belonging to the year 2017 through the revision of clinical stories 1190, by selecting 166 patients during the surgical intervention, 59 because of cataracts and 107 to pterygium. Subsequently sought information on: age, sex, marital status, origins, occupation, eye intervened, month of surgery, complications of previous health and cost of drug therapy prescribed, thus allowing to calculate the total cost that patients must pay for the same. Of the 166 patients, 33% men, with an average age of 61 years (range 21 to 87) and 67% of women, with a mean age of 59 years (range 20 to 89 years), belonged to the province of Chimborazo (87%) and other provinces (13%), with occupations such as agriculture, homemaker and none (62%) and others (38%). 20 were found for cataract treatment schemes and 15 for pterygium, using the pharmacoeconomics analysis: AMC, ACB and ACE, were chosen as the treatment of lower cost-effectiveness, The ET_3 ($130) for cataract cases complicated, ET_9 ($37) for non-complicated cataracts and the ET_2 ($52) for pterygium. We used the SPSS v23 software for statistical analysis, in evidence of inter-subject was the relationship between the cost of the pharmacotherapy with the treatment schemes, occupation, marital status, national origin and pathology (p≤0,05).